CONGRESS GUIDE
05.09.2016 • Views
Share Embed Flag

CONGRESS GUIDE

ExportFinalProgram_26082016041327

ExportFinalProgram_26082016041327

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
thromboadviser

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

ERS International Congress 2016<br />

DETAILED PROGRAMME<br />

MONDAY 05 SEPTEMBER, 2016<br />

PA2091<br />

PA2092<br />

PA2093<br />

PA2094<br />

PA2095<br />

PA2096<br />

PA2097<br />

PA2098<br />

PA2099<br />

PA2100<br />

PA2101<br />

Effect of pirfenidone on IPF progression<br />

Ginevra Del Giudice (Benevento, Italy), Diana Radicella, Ginevra Del Giudice, Assunta Micco, Mariano Mazza, Mario Del<br />

Donno<br />

Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis<br />

Sojung Park (Seoul, Republic of Korea), Sojung Park, Jisun Lee, Dong Soon Kim, Jin Woo Song<br />

Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis<br />

Eva Brunnemer (Heidelberg, Germany), Eva Brunnemer, Svenja Ehlers-Tenenbaum, Calus Peter Heussel, Arne Warth,<br />

Felix Herth, Michael Kreuter<br />

MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages<br />

Katerina Antoniou (Heraklion, Crete, Greece), Eliza Tsitoura, Athol U. Wells, Chara Koutoulaki, Konstantinos Karagiannis,<br />

Ismini Lasithiotaki, Eirini Vasarmidi, Hiroe Sato, Demetrios A. Spandidos, Nikolaos M. Siafakas, Georgios Sourvinos,<br />

Katerina Antoniou<br />

Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset<br />

responses in lung<br />

Kaustav Chakraborty (Kolkata, India), Kaustav Chakraborty, Arindam Bhattacharyya<br />

Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis<br />

HIROYUKI TANIGUCHI (Nisshin, Japan), Hiroyuki Taniguchi, Yasuhiro Kondoh, Taiki Furukawa, Tomoki Kimura,<br />

Kensuke Kataoka, Takeshi Johkoh, Junya Fukuoka, Keiko Hasegawa<br />

Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary<br />

fibrosis?<br />

Radwa Elhefny (Cairo, Egypt), Radwa Elhefny, Sabah Ahmed, Marwa Moawad, Mona Abdullatif<br />

Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis<br />

Hirotsugu Ohkubo (Nagoya, Japan), Hirotsugu Ohkubo, Mitsuaki Yagi, Yasuhiro Kondoh, Takeshi Johkoh, Hiroaki<br />

Arakawa, Akio Niimi, Hiroyuki Taniguchi<br />

First insights from the BTS idiopathic pulmonary fibrosis (IPF) registry<br />

Monica Spiteri (Stoke-on-Trent, United Kingdom), Monica Spiteri, William Chang, Nazia Chaudhuri, Robina K. Coker, Sue<br />

Copley, Owen Dempsey, Ian Forrest, Michael Gibbons, Ling-Pei Ho, Toby M. Maher, Helen Parfrey, Luca Richeldi, Lisa<br />

Spencer<br />

Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry<br />

Helen Jo (Sydney, NSW, Australia), Helen Jo, Ian Glaspole, Yuben Moodley, Sally Chapman, Wendy Cooper, Samantha<br />

Ellis, Nicole Goh, Peter Hopkins, Greg Keir, Annabelle Mahar, Paul Reynolds, Haydn Walters, Christopher Zappala,<br />

Christopher Grainge, Heather Allan, Tamera Corte<br />

Survival from acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with<br />

polymyxin B-immobilized fiber column: A retrospective analysis<br />

Keiji Oishi (Yamaguchi, Japan), Keiji Oishi, Keisuke Aoe, Yusuke Mimura, Yoriyuki Murata, Kenji Sakamoto, Wataru<br />

Koutoku, Tsuneo Matsumoto, Hiroshi Ueoka, Kazuto Mastunaga, Masafumi Yano<br />

PA2102<br />

A supportive care decision aid tool for idiopathic pulmonary fibrosis<br />

Charles Sharp (BRISTOL, United Kingdom), Charles Sharp, Adrienne Edwards, Heather Lamb, Sorayya Alam, Nikki<br />

Jordan, Rachel Gunary, Patricia Meek, Ann Millar, Clare Kendall, Huzaifa Adamali<br />

Room ICC Capital Suite 9 Session 368 10:45 - 12:45<br />

Poster Discussion: Active and latent tuberculosis: biomarkers<br />

Chairs : Morten Ruhwald (Copenhagen, Denmark), Jackie Cliff (London, United Kingdom)<br />

PA2103<br />

Impact of pulmonary tuberculosis sequelae on functional status<br />

isha garg (jodhpur, India), Laxman kumar Soni, Hemant Borana, Gopal Purohit, C.R. Choudhary, Isha Garg, Srikant<br />

Agarwal, Lalit Kumar Sharma, U. Narendra<br />

PA2104<br />

PA2105<br />

Tuberculosis in renal transplant recipients on isoniazid prophylaxis<br />

Sohail Akhtar (KARACHI, Pakistan), Sohail Akhtar, Asma Naseem, Sunil Dodani, Rubina Naqvi, Ejaz Ahmad, Anwar<br />

Naqvi, Adib Rizvi<br />

The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant<br />

candidates<br />

Balam Er Dedekarginoglu (ANKARA, Turkey), Balam Er Dedekarginoglu, Fusun Eyuboglu, Ozlem Salman Sever,<br />

Aydincan Akdur, Mehmet Haberal<br />

147 26.08.2016

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!